Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Teresa Yurik"'
Autor:
Grace Peng, Douglas L. Mayers, Barbara Brizz, Li Chen, C. Lynn Besch, Mary van den Berg-Wolf, Teresa Yurik, Barry Schmetter, Rodger D. MacArthur, Richard M. Novak, Donald I. Abrams
Publikováno v:
Controlled Clinical Trials. 22:176-190
The CPCRA (Terry Beirn Community Programs for Clinical Research on AIDS) 058 FIRST (Flexible Initial Retrovirus Suppressive Therapies) trial is a large, long-term, randomized, prospective comparison of three different antiretroviral strategies in hig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b4224f0520676540cbe36fd650f7193d
https://doi.org/10.1016/s0197-2456(01)00111-8
https://doi.org/10.1016/s0197-2456(01)00111-8
Autor:
Lawrence R. Crane, Stanley L. John, Donald I. Abrams, Roberta Luskin-Hawk, Janice Walker, Susan Caras, Teresa Yurik, Richard Hafner, Chris Pulling, Renslow Sherer, Ann Labriola, Wafaa El-Sadr
Publikováno v:
Clinical Infectious Diseases. 29:775-783
We enrolled 2,625 human immunodeficiency virus-infected patients into a randomized trial to assess the efficacy and tolerability of daily vs. thrice-weekly trimethoprim-sulfamethoxazole (160 mg/800 mg) for prophylaxis of Pneumocystis carinii pneumoni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95cc3d3fc9a297c6df8131ab771268b6
https://doi.org/10.1086/520433
https://doi.org/10.1086/520433
Autor:
Richard Hafner, Charles van der Horst, Robert L. Murphy, Thomas M. Hooton, Henry H. Balfour, Wafaa El-Sadr, Roberta Luskin-Hawk, Thomas Kerkering, Tony W. Cheung, Teresa Yurik, Robert H.K. Eng, Malte Schutz
Publikováno v:
New England Journal of Medicine. 339:1889-1895
Background Although trimethoprim–sulfamethoxazole is the drug of choice for the prevention of Pneumocystis carinii pneumonia, many patients cannot tolerate it and must switch to an alternative agent. Methods We conducted a multicenter, open-label,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5d004a064c3e3d9f0c10a2ea4f0ff57
https://doi.org/10.1056/nejm199812243392604
https://doi.org/10.1056/nejm199812243392604
Publikováno v:
Statistics in Medicine. 15:2445-2453
Many persons with HIV require and take several medications. The efficacy and safety of many of these medications are uncertain. Usually limited data on drug interactions are available. Thus simultaneous and sequential enrolment of patients into multi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b24469478a3e064d93a79773d559b12c
https://doi.org/10.1002/(sici)1097-0258(19961130)15:22<2445::aid-sim462>3.0.co
https://doi.org/10.1002/(sici)1097-0258(19961130)15:22<2445::aid-sim462>3.0.co
Autor:
Richard M. Novak, M. van den Berg-Wolf, C. Henley, Teresa Yurik, Grace Peng, Michael J. Kozal, Rodger D. MacArthur, Barry Schmetter, L. Besch, Marjorie Dehlinger, Li Chen
Publikováno v:
HIV clinical trials. 5(6)
Purpose: The combination of abacavir + lamivudine (ABC+3TC) versus didanosine + stavudine (ddI+d4T), each combined with other classes of antiretrovirals (ARVs) in ARV-naive patients, was compared for the combined endpoint of time to plasma HIV RNA >5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e11a717e134fa114ac174bc1f94b548
https://pubmed.ncbi.nlm.nih.gov/15682349
https://pubmed.ncbi.nlm.nih.gov/15682349